CRESEMBA QUICK START+® Program

The CRESEMBA QUICK START+® Program provides a one-time, 7-day supply of CRESEMBA® (isavuconazonium sulfate) capsules at no cost to eligible new adult patients who experience an insurance-related delay.

  • To be eligible for the QUICK START+ Program, patients must:
    • Have prescription drug insurance
    • Be new to CRESEMBA therapy
    • Have experienced an insurance-related access delay
    • Have been prescribed CRESEMBA for an FDA-approved indication
  • Offers overnight shipping directly to the patienta

a Provided request is submitted by 3:00 pm ET.

QUICK START+® is a registered trademark of Astellas US LLC.

CRESEMBA® is a registered trademark of Astellas Pharma Inc.